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Abstract
Background: There is strong evidence that an individual's genetic background is an important
predisposing factor to longevity. In the present study we analysed the frequency of HLA class I, class
II, as well as the TNF-α -308 polymorphism that may be related to an increased life span in Mexican
Mestizo healthy elders.
Results:  HLA typing was performed by polymerase chain reaction sequence specific
oligonucleotide (PCR SSO) reverse dot blot. The TNF-α -308 polymorphism was assessed by PCR
restriction fragment length polymorphism. A significant increased frequency of HLA-DRB1*11 was
found in elderly women whereas this allele was not present in elderly males. The TNF2 allele was
also increased in the elder group when compared to young controls. The frequencies of the
remaining alleles tested were not statistically different among groups.
Conclusion: These data suggest an ethnicity independent tendency of HLA-DRB1*11 in elder
females to increase life span and a possible role of the TNF2 allele with the successful remodelling
of senescent immune system.
Background
Ageing is associated with a complex remodelling of the
immune system often in the direction of apparently
decreased immune competence. However, it has been
proposed that longevity is related to optimal function of
the immune system because some genetic determinants
for successful ageing might reside in those polymor-
phisms of genes that regulate immune responses e.g.
major histocompatibility complex (MHC) [1,2]. The stud-
ies of life span in humans have resulted in different, and
even controversial, associations of HLA class I, class II and
class III genes with old age. Thus, longevity has been
shown to be related with the selection of HLA alleles or
haplotypes being the more frequently associated the A1
B8 Cw7 DR3 in Caucasians [3,4], the increased or
decreased frequency of HLA-B40 [5-7], the augmented fre-
quency of HLA-DR11 in elder women in Caucasian as
well as in Japanese populations [8,9] among other alleles.
Immunogenetic studies in aged, healthy Mexican Mestizo
population have not been yet performed.
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Mexican Mestizo individuals have a proportion of 56%
Native American Indian genes, 40% Caucasian genes, and
4% African genes [10]. Mestizo population represents a
complex mixture of European and American native inhab-
itants, and constitute the core of the Mexican population.
This complex genetic process began in the 16th century
and has been expanded during the course of time and
continues to be a dynamic process, e.g., African popula-
tion inhabited the Americas almost 200 years later. On the
other hand, aged people in the Mexican population have
increased from a life expectancy of 63 years in the 1970's
up to 70 years nowadays.
Healthy elderly people show a pro-inflammatory pheno-
type with increased levels of cytokines such as TNF-α [11].
The TNF-α gene is located within the HLA class III region.
This cytokine is involved in tissue remodelling, epithelial
cell barrier permeability, macrophage activation, recruit-
ment of inflammatory infiltrate, and up-regulation of
adhesion molecules, among other functions. TNF-α also
determines the strength, effectiveness and duration of
local and systemic inflammatory responses [12].
TNF-α promoter contains numerous polymorphic sites,
which are possible targets for transcription factors. The
polymorphism at position -308 is defined by de substitu-
tion of a G by an A, where the presence of G defines the
common allele TNF1 and A defines the TNF2 variant,
which is less frequent [13]. Some studies have shown that
individuals bearing the TNF2 polymorphism are higher
TNF-α producers than those who bear the TNF1 variant
[14].
The aim of this study was to evaluate the class I, class II
HLA genotypes as well as the TNF-α -308 polymorphism
with successful ageing in Mexican Mestizo.
Results and Discussion
Of the 71 elders, 38 (53.5%) were females and 33
(46.5%) males. Results of the observed and expected anti-
gen and genotype frequencies for HLA-B, -DRB1 and -
DQB1 loci were consistent with those predicted by the
Hardy-Weinberg equilibrium. It is worth mentioning that
the frequencies identified in our population are similar
from those reported in previous studies performed in
Mexican Mestizo populations [10].
Gene frequencies at the HLA-DRB1 locus were not statis-
tically significant different among groups. The most fre-
quent allele in both, young subjects and elders, was the
HLA-DRB1*04. The high resolution typing revealed that
the more frequent alleles in the elderly group were HLA-
DRB1*0802, DRB1*0701, DRB1*0404 and DRB1*0407,
whereas HLA-DRB1*0802, DRB1*0701, DRB1*1101 and
DRB1*0404 were the more frequent in the young group,
being these alleles not statistically significant.
When the differences between aged males and females
were analysed, a decreased frequency of HLA-DRB1*11 in
males was found when compared to females, for no one
in the former group was HLA-DRB1*11 (p = 0.002; OR =
0.18; CI 95% = 0.06–0.53; p = 0.024 by Bonferroni's cor-
rection). On the other hand, when elderly males were
compared to young males for HLA-DRB1*11, a dimin-
ished frequency was found although not statistically sig-
nificant when Bonferroni's correction was applied. The
high resolution typing showed a decreased frequency of
the HLA-DRB1*1101 allele in elderly females when com-
pared to the other HLA-DRB1*11 alleles from young
women and, again, this difference was not significant by
Bonferroni's correction.
Our data must be balanced against the small number of
subjects studied. However, we found that, interestingly,
no old man was HLA-DRB1*11, which may suggest that
survival being gender-dependent [15,16]. This finding for
Mexican Mestizo women is in agreement with previous
reports in different populations, which might indicate
that the contribution of this allele to an increase in the life
span is independent of ethnicity [8].
Concerning the HLA-B and HLA-DQB1 alleles, no differ-
ences were observed among elders and young controls nor
when compared by gender. The high resolution typing of
HLA-DQB1 showed that in the elderly group the most fre-
quent subtypes were HLA-DQB1*0302, DQB1*0402 and
DQB1*0501 whereas in the young group were the HLA-
DQB1*0302, DQB1*0301, DQB1*0402 and
DQB1*0201. Finally, the generic typing of the HLA-B
locus showed that the more frequent alleles in both
groups were HLA-B*35 and HLA -B*15. A decreased ten-
dency in the HLA-B*14 frequency in the elder group was
also observed when compared to that of the control
group, although this was not statistically significant.
The analysis of the TNF-α -308 promoter polymorphism
showed a diminished frequency of the TNF1 allele accom-
panied by an increased one in the TNF2 allele in elders.
The heterozygote genotype TNF1/2 was more common in
the elderly group (9.02%) than in the control group
(1.5%) (Table 1). Serum levels of TNF-α showed a slight
increase in the elderly group although this difference was
not statistically significant (data not shown). Interest-
ingly, it was found that 58% of the TNF2 individuals were
HLA-DR3 and HLA-DR4. The -308A TNF-α polymor-
phism has been shown to vary between individuals. These
variants have been associated with certain HLA-DR alleles,
e.g., HLA-DR2 subjects are considered low TNF-  produc- α .Immunity & Ageing 2005, 2:13 http://www.immunityageing.com/content/2/1/13
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ers while those bearing HLA-DR3 and HLA-DR4 alleles
produce high levels of this cytokine [13,14,17-19]
The TNF2 genotype has been related to an increased
cytokine transcription rate [20]. Furthermore, it has been
proposed that individuals who are heterozygous for this
polymorphism possess an optimal inflammatory
response that protects them against age-related neurode-
generation [21]. Although the inflammatory process has
been related to chronic illnesses, incapacity, and death, it
is interesting that in healthy old people this pro-inflam-
matory phenotype may be involved in the remodeling of
the cytokine network which contributes to the successful
ageing process [22]. Notwithstanding, lack of such associ-
ation has also been reported [23,24].
Conclusion
Longevity studies must ideally include healthy centenari-
ans, as they represent the extreme of human old age. Most
studies carried out on centenarians come from either
Europe or Asiatic countries such as Japan. It is precisely in
these regions that the largest numbers of centenarians can
be found. This is closely related on the one hand, with the
social, cultural, and economic conditions of developed
countries and, on the other, with biological factors includ-
ing the long history of their ethnic groups, which has per-
mitted a natural selection of genes favouring longevity
[25]. By contrast, the ethnic group known as Mexican
Mestizo is, in evolutionary terms, a recent one barely 500
years old. This lapse is certainly not enough to establish an
allele selection or, even, modify completely the structure
of previous haplotypes by the genetic admixture process
that could account to change certain HLA clusters of Mex-
ican natives. On the other hand, infectious diseases
imported by conquerors indeed, have influenced the
selection of HLA repertoire in our region. The cultural and
socio-economic conditions of our geographical zone
(Mexico and Central America) have contributed to a
marked increase in life expectancy, particularly over the
last 50 years, even though this is still far removed from
that of developed countries. It is worth mentioning that
the mean age of our study group is at least 10 years greater
than the current life expectancy for Mexico and, hence,
they represent the oldest population that have enjoyed
successful ageing within our country.
Certainly, a great diversity of genes and factors influence
successful ageing. Single nucleotide polymorphisms
located in cytokine gene promoters have been demon-
strated to affect the binding of transcription factors and,
hence, its gene expression. Genetic variants that deter-
mine an increased production of anti-inflammatory
cytokines or a decreased one of pro-inflammatory
cytokines have been associated with successful ageing,
suggesting a role in the control of the inflammatory state
in the attainment of increased life span [12,26,27].
Moreover, the study of polymorphic genes on the X chro-
mosome do not have to be procrastinated for there are
some – albeit relatively old – evidence that they are critical
in the genetic regulation of the immune response and
thus could be of utmost importance for conditioning the
life span expectancy [28-30].
Methods
Subjects
A total of 71 healthy elders were studied, age ranged from
80 to 96 years (mean 86.2 years). The control samples
were obtained from 99 young (from 21 – 54 years; mean
35.2 years) healthy individuals unrelated to elders. All
subjects were Mexican Mestizo which is defined as an
individual who was born in Mexico and is descendent
from mixed racial ancestry of the native Americans of such
region with individuals from Europe (mainly Spain) or
Africa, all of them living in Mexico City. A complete social
and medical history and physical examination was per-
formed. Laboratory tests included complete blood cell
count, erythrocyte sedimentation rate (Westergreen),
immunoglobulin levels (IgG, IgA, IgM), serum electro-
lytes, glucose, creatinine, urea, alkaline phosphatase,
aspartate transaminase, total bilirubin, and total choles-
terol. All subjects were informed about the objectives and
methods of the study. Work has been done according to
current law.
DNA isolation
Genomic DNA was extracted from 5 mL of peripheral
whole blood employing the Wizard genomic DNA purifi-
cation kit (Promega, Madison, WI) according to manufac-
turer's instructions. Isolated DNA was quantified by
Table 1: TNF-α -308 polymorphism in elderly and young adults.
Healthy elders (n = 72) Young controls (n = 198) Statistics
gf (n = 144) gf (n = 110) P OR CI 95%
TNF1 0.909 0.985 NS - -
TNF2 0.090 0.015 0.001 0.33 0.14–0.73
gf = gene frequency; OR = Odds ratio; CI = Confidence interval; NS: non significant.Immunity & Ageing 2005, 2:13 http://www.immunityageing.com/content/2/1/13
Page 4 of 5
(page number not for citation purposes)
spectrophotometry and adjusted to a concentration of
100 ng/µL, and stored at -70°C until use.
HLA Typing
Generic HLA-DRB1, DQB1, and HLA-B typing was per-
formed by polymerase chain reaction sequence specific
oligonucleotide (PCR-SSO) reverse dot blot using the
Dynal RELI SSO system (Hoffman-La Roche Ltd. and
Roche Molecular Systems, Inc., Alameda, CA) as described
previously [31]. High resolution typing of HLA-DRB1 and
DQB1 loci was done by sequence based typing method
(SBT). The primers' sequences and PCR conditions for
amplification of polymorphic exons were obtained from
protocols of the 13th  International Histocompatibility
Workshop (Seattle, 2002).
TNF-α-308 polymorphism
Genotyping for the TNF-α -308 polymorphism was per-
formed using a PCR fragment amplified using the forward
primer 5'-AGG CAA TAG GTT TTG AGG GCC AT-3' and
the reverse primer 5'-TCC TCC CTG CTC CGA TTC CG-3'
to create a restriction site for the NcoI endonuclease (Fer-
mentas, Hanover, MD) according to previous reports [32].
Digestion products were analysed by photo typing in 2%
agarose gels and stained with ethidium bromide. Only 55
healthy young subjects were analysed for this polymor-
phism.
TNF-α serum levels
Serum from each subject was obtained from 5 mL whole
blood and stored at -70°C until tested. An ELISA kit was
used for the measurement of TNF-α levels according to
manufacturer's instructions (R&D Systems, Minneapolis,
MN).
Statistics
Allele frequencies were evaluated by gene count and 2 × 2
contingency tables. Statistical differences of allele fre-
quencies between elders and controls were done employ-
ing chi square test and Yate's correction. Obtained P
values were subjected to Bonferroni's correction. Odds
ratio was calculated for healthy elders' carriers of specific
alleles. Data were tested for the goodness of fit between
the observed and expected genotype values and their fit to
Hardy-Weinberg equilibrium.
List of Abbreviations
HLA Human Leukocyte Antigen
TNF Tumor Necrosis Factor
PCR Polymerase Chain Reaction
PCR SSO Polymerase Chain Reaction Sequence Specific
Oligonucleotide
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